Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment

Since more than 40 years liposomes have being extensively studied for their potential as carriers of anticancer drugs. The basic principle behind their use for cancer treatment consists on the idea that they can take advantage of the leaky vasculature and poor lymphatic drainage present at the tumor...

Full description

Bibliographic Details
Main Authors: Marina Santiago Franco, Eliza Rocha Gomes, Marjorie Coimbra Roque, Mônica Cristina Oliveira
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.623760/full
id doaj-328ae09459974bb1a3d7304031ae9e4c
record_format Article
spelling doaj-328ae09459974bb1a3d7304031ae9e4c2021-03-16T06:25:04ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.623760623760Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor EnvironmentMarina Santiago FrancoEliza Rocha GomesMarjorie Coimbra RoqueMônica Cristina OliveiraSince more than 40 years liposomes have being extensively studied for their potential as carriers of anticancer drugs. The basic principle behind their use for cancer treatment consists on the idea that they can take advantage of the leaky vasculature and poor lymphatic drainage present at the tumor tissue, passively accumulating in this region. Aiming to further improve their efficacy, different strategies have been employed such as PEGlation, which enables longer circulation times, or the attachment of ligands to liposomal surface for active targeting of cancer cells. A great challenge for drug delivery to cancer treatment now, is the possibility to trigger release from nanosystems at the tumor site, providing efficacious levels of drug in the tumor. Different strategies have been proposed to exploit the outer and inner tumor environment for triggering drug release from liposomes and are the focus of this review.https://www.frontiersin.org/articles/10.3389/fonc.2021.623760/fullcancerchemotherapyliposometriggered releasetumor environment
collection DOAJ
language English
format Article
sources DOAJ
author Marina Santiago Franco
Eliza Rocha Gomes
Marjorie Coimbra Roque
Mônica Cristina Oliveira
spellingShingle Marina Santiago Franco
Eliza Rocha Gomes
Marjorie Coimbra Roque
Mônica Cristina Oliveira
Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
Frontiers in Oncology
cancer
chemotherapy
liposome
triggered release
tumor environment
author_facet Marina Santiago Franco
Eliza Rocha Gomes
Marjorie Coimbra Roque
Mônica Cristina Oliveira
author_sort Marina Santiago Franco
title Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
title_short Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
title_full Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
title_fullStr Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
title_full_unstemmed Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
title_sort triggered drug release from liposomes: exploiting the outer and inner tumor environment
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-03-01
description Since more than 40 years liposomes have being extensively studied for their potential as carriers of anticancer drugs. The basic principle behind their use for cancer treatment consists on the idea that they can take advantage of the leaky vasculature and poor lymphatic drainage present at the tumor tissue, passively accumulating in this region. Aiming to further improve their efficacy, different strategies have been employed such as PEGlation, which enables longer circulation times, or the attachment of ligands to liposomal surface for active targeting of cancer cells. A great challenge for drug delivery to cancer treatment now, is the possibility to trigger release from nanosystems at the tumor site, providing efficacious levels of drug in the tumor. Different strategies have been proposed to exploit the outer and inner tumor environment for triggering drug release from liposomes and are the focus of this review.
topic cancer
chemotherapy
liposome
triggered release
tumor environment
url https://www.frontiersin.org/articles/10.3389/fonc.2021.623760/full
work_keys_str_mv AT marinasantiagofranco triggereddrugreleasefromliposomesexploitingtheouterandinnertumorenvironment
AT elizarochagomes triggereddrugreleasefromliposomesexploitingtheouterandinnertumorenvironment
AT marjoriecoimbraroque triggereddrugreleasefromliposomesexploitingtheouterandinnertumorenvironment
AT monicacristinaoliveira triggereddrugreleasefromliposomesexploitingtheouterandinnertumorenvironment
_version_ 1724219968178880512